Loewen Andrea

Officer at REATA PHARMACEUTICALS INC

Sold, on record
$2.9M
Dollars the filings state
Form 4 sales
4
Latest Sep 14, 2023
Form 144 notices
4
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale REATA PHARMACEUTICALS INCPlan not stated
    Mar 3 2023

    Sold 1,819 shares at $88.08 ($160k)

    Loewen Andrea, SVP, Global Regulatory Affairs

    Sold 4.1% of holdings ($3.9M position)42,793 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale REATA PHARMACEUTICALS INCUnusual
    Mar 7 +4 days

    Sold 19,036 shares at $83.43 ($1.6M)

    Loewen Andrea, SVP, Global Regulatory Affairs

    Sold 32.9% of holdings ($4.8M position)38,757 shares leftFiling

  3. 3 Form 144 notice REATA PHARMACEUTICALS INCNotice
    May 12 +66 days

    Filed to sell 6,750 shares ($582k)

    Loewen Andrea, Officer

    No 10b5-1 planFiling

  4. 4 Form 144 notice REATA PHARMACEUTICALS INCNotice
    May 15 +3 days

    Filed to sell 103 shares ($9k)

    Loewen Andrea, Officer

    No 10b5-1 planFiling

  5. 5 Form 4 sale REATA PHARMACEUTICALS INCNo plan
    May 16 +1 day

    Sold 7,166 shares at $86.01 ($616k)

    Loewen Andrea, SVP, Global Regulatory Affairs

    No 10b5-1 planSold 18.5% of holdings ($3.3M position)31,591 shares leftFollows a Form 144Filing

  6. 6 Form 144 notice REATA PHARMACEUTICALS INCNotice
    May 16 same day

    Filed to sell 313 shares ($25k)

    Loewen Andrea, Officer

    No 10b5-1 planFiling

  7. 7 Form 144 notice REATA PHARMACEUTICALS INCNotice
    Sep 14 +121 days

    Filed to sell 3,175 shares ($546k)

    Loewen Andrea, Officer

    No 10b5-1 plan0.4x usual sizeFiling

  8. 8 Form 4 sale REATA PHARMACEUTICALS INCNo plan
    Sep 14 same day

    Sold 3,175 shares at $172.03 ($546k)

    Loewen Andrea, SVP, Global Regulatory Affairs

    No 10b5-1 planSold 10.1% of holdings ($5.4M position)28,416 shares left0.4x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Loewen Andrea
Source
Sep 14, 2023REATA PHARMACEUTICALS INCSVP, Global Regulatory AffairsForm 4 sale3,175$546k10.1%No planSEC
Sep 14, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice3,175$546kNoticeSEC
May 16, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice313$25kNoticeSEC
May 16, 2023REATA PHARMACEUTICALS INCSVP, Global Regulatory AffairsForm 4 sale7,166$616k18.5%No planSEC
May 15, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice103$9kNoticeSEC
May 12, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice6,750$582kNoticeSEC
Mar 7, 2023REATA PHARMACEUTICALS INCSVP, Global Regulatory AffairsForm 4 sale19,036$1.6M32.9%UnusualSEC
Mar 3, 2023REATA PHARMACEUTICALS INCSVP, Global Regulatory AffairsForm 4 sale1,819$160k4.1%Plan not statedSEC